Register entry

Shorla Oncology Inc.,

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Labeller names
3
Live patents
1
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: ANDA 2, NDA 2.

Dosage formNDCs
injection2
solution2
RouteNDCs
intravenous2
oral2
Labeller name on the listingNDCs
shorla oncology inc.2
shorla oncology inc.1
shorla oncology inc.,1
Exclusivity

Patents and exclusivities

1
PatentProductCoversExpiry
11957681IMKELDIimatinib mesylateproductApr 2040
Catalogue

Marketed products

6

Showing 4 of 6.

BrandGeneric nameForm / routeNDC
IMKELDIimatinib oralsolution, oral81927-201NDA
JYLAMVOMethotrexatesolution, oral81927-204NDA
nelarabinenelarabineinjection, intravenous81927-111ANDA
nelarabinenelarabineinjection, intravenous81927-375ANDA
Compare

Other companies listing nelarabine

Enquiry

Common questions

Is Shorla Oncology Inc., FDA approved?
Shorla Oncology Inc., holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Shorla Oncology Inc., make?
6 products are listed under Shorla Oncology Inc., in the openFDA NDC Directory, most often as injection; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.